_version_ 1785039343163801600
author Ferreras, C.
Hernández, C.
Martín-Quirós, A.
Al-Akioui-Sanz, K.
Mora-Rillo, M.
Ibáñez, F.
Goterris, R.
de Paz, R.
Guerra-García, P.
Queiruga-Parada, J.
Molina, P.
Briones, M.
Planelles, D.
Borobia, A.M.
Carcas, A.
Vicario, J.L.
Moreno, M.
Balas, A.
Eguizabal, C.
Soria, B.
Solano, C.
Perez-Martinez, A.
author_facet Ferreras, C.
Hernández, C.
Martín-Quirós, A.
Al-Akioui-Sanz, K.
Mora-Rillo, M.
Ibáñez, F.
Goterris, R.
de Paz, R.
Guerra-García, P.
Queiruga-Parada, J.
Molina, P.
Briones, M.
Planelles, D.
Borobia, A.M.
Carcas, A.
Vicario, J.L.
Moreno, M.
Balas, A.
Eguizabal, C.
Soria, B.
Solano, C.
Perez-Martinez, A.
author_sort Ferreras, C.
collection PubMed
description
format Online
Article
Text
id pubmed-10171023
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher International Society for Cell & Gene Therapy. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-101710232023-05-10 Immunotherapy: EVALUATION OF MEMORY T CELLS AS ADOPTIVE THERAPY IN CORONAVIRUS PNEUMONIA AND/OR LYMPHOPENIA: A PHASE II CLINICAL TRIAL (RELEASE NCT04578210) Ferreras, C. Hernández, C. Martín-Quirós, A. Al-Akioui-Sanz, K. Mora-Rillo, M. Ibáñez, F. Goterris, R. de Paz, R. Guerra-García, P. Queiruga-Parada, J. Molina, P. Briones, M. Planelles, D. Borobia, A.M. Carcas, A. Vicario, J.L. Moreno, M. Balas, A. Eguizabal, C. Soria, B. Solano, C. Perez-Martinez, A. Cytotherapy Oral Abstracts International Society for Cell & Gene Therapy. Published by Elsevier Inc. 2023-05 2023-05-10 /pmc/articles/PMC10171023/ http://dx.doi.org/10.1016/S1465-3249(23)00178-0 Text en Copyright © 2023 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Oral Abstracts
Ferreras, C.
Hernández, C.
Martín-Quirós, A.
Al-Akioui-Sanz, K.
Mora-Rillo, M.
Ibáñez, F.
Goterris, R.
de Paz, R.
Guerra-García, P.
Queiruga-Parada, J.
Molina, P.
Briones, M.
Planelles, D.
Borobia, A.M.
Carcas, A.
Vicario, J.L.
Moreno, M.
Balas, A.
Eguizabal, C.
Soria, B.
Solano, C.
Perez-Martinez, A.
Immunotherapy: EVALUATION OF MEMORY T CELLS AS ADOPTIVE THERAPY IN CORONAVIRUS PNEUMONIA AND/OR LYMPHOPENIA: A PHASE II CLINICAL TRIAL (RELEASE NCT04578210)
title Immunotherapy: EVALUATION OF MEMORY T CELLS AS ADOPTIVE THERAPY IN CORONAVIRUS PNEUMONIA AND/OR LYMPHOPENIA: A PHASE II CLINICAL TRIAL (RELEASE NCT04578210)
title_full Immunotherapy: EVALUATION OF MEMORY T CELLS AS ADOPTIVE THERAPY IN CORONAVIRUS PNEUMONIA AND/OR LYMPHOPENIA: A PHASE II CLINICAL TRIAL (RELEASE NCT04578210)
title_fullStr Immunotherapy: EVALUATION OF MEMORY T CELLS AS ADOPTIVE THERAPY IN CORONAVIRUS PNEUMONIA AND/OR LYMPHOPENIA: A PHASE II CLINICAL TRIAL (RELEASE NCT04578210)
title_full_unstemmed Immunotherapy: EVALUATION OF MEMORY T CELLS AS ADOPTIVE THERAPY IN CORONAVIRUS PNEUMONIA AND/OR LYMPHOPENIA: A PHASE II CLINICAL TRIAL (RELEASE NCT04578210)
title_short Immunotherapy: EVALUATION OF MEMORY T CELLS AS ADOPTIVE THERAPY IN CORONAVIRUS PNEUMONIA AND/OR LYMPHOPENIA: A PHASE II CLINICAL TRIAL (RELEASE NCT04578210)
title_sort immunotherapy: evaluation of memory t cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: a phase ii clinical trial (release nct04578210)
topic Oral Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171023/
http://dx.doi.org/10.1016/S1465-3249(23)00178-0
work_keys_str_mv AT ferrerasc immunotherapyevaluationofmemorytcellsasadoptivetherapyincoronaviruspneumoniaandorlymphopeniaaphaseiiclinicaltrialreleasenct04578210
AT hernandezc immunotherapyevaluationofmemorytcellsasadoptivetherapyincoronaviruspneumoniaandorlymphopeniaaphaseiiclinicaltrialreleasenct04578210
AT martinquirosa immunotherapyevaluationofmemorytcellsasadoptivetherapyincoronaviruspneumoniaandorlymphopeniaaphaseiiclinicaltrialreleasenct04578210
AT alakiouisanzk immunotherapyevaluationofmemorytcellsasadoptivetherapyincoronaviruspneumoniaandorlymphopeniaaphaseiiclinicaltrialreleasenct04578210
AT morarillom immunotherapyevaluationofmemorytcellsasadoptivetherapyincoronaviruspneumoniaandorlymphopeniaaphaseiiclinicaltrialreleasenct04578210
AT ibanezf immunotherapyevaluationofmemorytcellsasadoptivetherapyincoronaviruspneumoniaandorlymphopeniaaphaseiiclinicaltrialreleasenct04578210
AT goterrisr immunotherapyevaluationofmemorytcellsasadoptivetherapyincoronaviruspneumoniaandorlymphopeniaaphaseiiclinicaltrialreleasenct04578210
AT depazr immunotherapyevaluationofmemorytcellsasadoptivetherapyincoronaviruspneumoniaandorlymphopeniaaphaseiiclinicaltrialreleasenct04578210
AT guerragarciap immunotherapyevaluationofmemorytcellsasadoptivetherapyincoronaviruspneumoniaandorlymphopeniaaphaseiiclinicaltrialreleasenct04578210
AT queirugaparadaj immunotherapyevaluationofmemorytcellsasadoptivetherapyincoronaviruspneumoniaandorlymphopeniaaphaseiiclinicaltrialreleasenct04578210
AT molinap immunotherapyevaluationofmemorytcellsasadoptivetherapyincoronaviruspneumoniaandorlymphopeniaaphaseiiclinicaltrialreleasenct04578210
AT brionesm immunotherapyevaluationofmemorytcellsasadoptivetherapyincoronaviruspneumoniaandorlymphopeniaaphaseiiclinicaltrialreleasenct04578210
AT planellesd immunotherapyevaluationofmemorytcellsasadoptivetherapyincoronaviruspneumoniaandorlymphopeniaaphaseiiclinicaltrialreleasenct04578210
AT borobiaam immunotherapyevaluationofmemorytcellsasadoptivetherapyincoronaviruspneumoniaandorlymphopeniaaphaseiiclinicaltrialreleasenct04578210
AT carcasa immunotherapyevaluationofmemorytcellsasadoptivetherapyincoronaviruspneumoniaandorlymphopeniaaphaseiiclinicaltrialreleasenct04578210
AT vicariojl immunotherapyevaluationofmemorytcellsasadoptivetherapyincoronaviruspneumoniaandorlymphopeniaaphaseiiclinicaltrialreleasenct04578210
AT morenom immunotherapyevaluationofmemorytcellsasadoptivetherapyincoronaviruspneumoniaandorlymphopeniaaphaseiiclinicaltrialreleasenct04578210
AT balasa immunotherapyevaluationofmemorytcellsasadoptivetherapyincoronaviruspneumoniaandorlymphopeniaaphaseiiclinicaltrialreleasenct04578210
AT eguizabalc immunotherapyevaluationofmemorytcellsasadoptivetherapyincoronaviruspneumoniaandorlymphopeniaaphaseiiclinicaltrialreleasenct04578210
AT soriab immunotherapyevaluationofmemorytcellsasadoptivetherapyincoronaviruspneumoniaandorlymphopeniaaphaseiiclinicaltrialreleasenct04578210
AT solanoc immunotherapyevaluationofmemorytcellsasadoptivetherapyincoronaviruspneumoniaandorlymphopeniaaphaseiiclinicaltrialreleasenct04578210
AT perezmartineza immunotherapyevaluationofmemorytcellsasadoptivetherapyincoronaviruspneumoniaandorlymphopeniaaphaseiiclinicaltrialreleasenct04578210